{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:35:23Z","timestamp":1779392123920,"version":"3.53.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,18]]},"abstract":"<jats:p>Pentraxin-3 (PTX-3) is a multibiological protein involved in cumulus cell expansion, fertilization, and implantation. This study was designed to analyze how circulating PTX-3 levels change in women with polycystic ovary syndrome (PCOS). A total of 50 Turkish participants, 35 of whom had PCOS and 15 of whom were fertile, were included in the study. Patients in the PCOS group were divided into 4 different phenotypes according to the NIH criteria (phenotypes A\u2013D). The number of patients in phenotype A was the highest 13 (37.1%). In the calculations made without phenotyping, the serum ptx3 levels of the PCOS group were found to be significantly lower compared to the fertile control group (3.32\u2005\u00b1\u20050.73\u2009ng\/mL vs 4.97\u2005\u00b1\u20051.29\u2009ng\/mL; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001). The ptx3 value of phenotypes A and B was significantly lower than phenotype D (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.008 and <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.009, respectively). When the phenotypes were compared with the fertile control group, the PTX-3 levels of phenotypes A and B were significantly lower than the fertile group. Although the ptx3 levels of phenotypes C and D were lower than the fertile group, the difference did not reach statistical significance. This is the first study to investigate serum ptx3 levels by phenotype in PCOS. While serum PTX-3 levels decreased in phenotypes A and B, ptx3 levels in phenotypes C and D were similar in fertile patients.<\/jats:p>","DOI":"10.1097\/md.0000000000040155","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:06:18Z","timestamp":1730138778000},"page":"e40155","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Serum pentraxin-3 expression varies according to polycystic ovary syndrome phenotypes"],"prefix":"10.1097","volume":"103","author":[{"given":"Fatma","family":"Tan\u0131l\u0131r \u00c7a\u011f\u0131ran","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Private Gynecology and Diseases Clinic, Diyarbakir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Mavral","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Private Lotus Hospital, \u015eanliurfa, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7128-7550","authenticated-orcid":false,"given":"Zercan","family":"Kal\u0131","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Private G\u00f6zde Hospital, Malatya, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7701-7826","authenticated-orcid":false,"given":"Seval M\u00fczeyyen","family":"Ecin","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine and Internal Medicine, Mersin City Training and Research Hospital, Mersin, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12958-022-00967-6","article-title":"The role of ERK-1 and ERK-2 gene polymorphisms in PCOS pathogenesis.","volume":"20","author":"Guney","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"R3-20250503","first-page":"1","article-title":"Epidemiology, diagnosis, and management of polycystic ovary syndrome.","volume":"6","author":"Sirmans","year":"2014","journal-title":"Clin Epidemiol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline.","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14715\/cmb\/2019.65.3.5","article-title":"Molecular role of peptides\/proteins in subfertility of polycystic ovarian syndrome.","volume":"65","author":"Celik","year":"2019","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12958-015-0134-9","article-title":"Role of anti-M\u00fcllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review.","volume":"13","author":"Dumont","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome.","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"R9-20250503","first-page":"300","article-title":"Effect of obesity on clinical parameters and pregnancy rates in women with polycystic ovary syndrome undergoing ovulation induction cycles.","volume":"62","author":"Tokmak","year":"2017","journal-title":"J Reprod Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: a comprehensive review.","volume":"27","author":"Palomba","year":"2021","journal-title":"Hum Reprod Update"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1515\/cclm-2012-0459","article-title":"Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.","volume":"51","author":"Kao","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1242\/dev.01056","article-title":"PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization.","volume":"131","author":"Salustri","year":"2004","journal-title":"Development"},{"issue":"suppl 2","key":"R13-20250503","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0264-410X(03)00199-3","article-title":"Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity.","volume":"21","author":"Mantovani","year":"2003","journal-title":"Vaccine"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12958-023-01176-5","article-title":"Long pentraxin 3 and vitamin D receptor mRNA expression pattern of cumulus granulosa cells isolated from PCOS oocytes at different stages of nuclear maturation.","volume":"22","author":"Ersahin","year":"2024","journal-title":"Reprod Biol Endocrinol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1182\/blood.V96.13.4300","article-title":"The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells.","volume":"96","author":"Rovere","year":"2000","journal-title":"Blood"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mrd.20013","article-title":"Pleiotropic effects of Hoxa10 on the functional development of peri-implantation endometrium.","volume":"67","author":"Daftary","year":"2004","journal-title":"Mol Reprod Dev"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/en.2007-1302","article-title":"The long pentraxin PTX3 in human endometrium: regulation by steroids and trophoblast products.","volume":"149","author":"Popovici","year":"2008","journal-title":"Endocrinology"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10815-021-02105-4","article-title":"Elevated ovarian pentraxin 3 in polycystic ovary syndrome.","volume":"38","author":"Pan","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/EJE-13-0761","article-title":"Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome.","volume":"170","author":"Tosi","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"R20-20250503","first-page":"3512","article-title":"Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity?","volume":"7","author":"Sahin","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12902-021-00886-4","article-title":"Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study.","volume":"21","author":"Jin","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3109\/09513590.2011.652719","article-title":"High plasma level of long pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.","volume":"28","author":"Aydogdu","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1210\/jc.2002-021072","article-title":"Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome.","volume":"88","author":"Cermik","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1380176","DOI":"10.1155\/2020\/1380176","article-title":"Pentraxin 3 levels in young women with and without polycystic ovary syndrome (PCOS) in relation to the nutritional status and systemic inflammation.","volume":"2020","author":"Wyskida","year":"2020","journal-title":"Int J Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:19:01Z","timestamp":1746317941000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":24,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040155","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]}}}